Pediatric HESI 2023 Related

Review Pediatric HESI 2023 related questions and content

Which treatment is instituted for the therapeutic management of minimal change nephrotic syndrome?

  • A. corticosteroids
  • B. antihypertensive agents
  • C. long-term diuretics
  • D. increased fluids to promote diuresis
Correct Answer: A

Rationale: Corticosteroids are the mainstay of treatment for minimal change nephrotic syndrome as they help reduce inflammation and decrease proteinuria. Antihypertensive agents are used to manage high blood pressure often associated with kidney disease but are not the primary treatment for this condition. Long-term diuretics are not typically used in the management of minimal change nephrotic syndrome as they can worsen fluid and electrolyte imbalances. Increasing fluids to promote diuresis is not recommended in this condition as it can lead to further fluid retention and edema.